Literature DB >> 31641385

Comprehensive analysis of competing endogenous RNA networks associated with cholangiocarcinoma.

Fangting Xu1, Yuchong Zhao2, Gang Qin1, Ye Huan1, Longyan Li1, Wei Gao1.   

Abstract

Cholangiocarcinoma (CCA) is the second most common type of primary malignancy of the liver. Certain long non-coding RNAs (lncRNAs) have been demonstrated to have key roles in tumor pathogenesis by binding to microRNAs (miRNAs). However, the competing endogenous RNA (ceRNA) network of CCA remains to be fully determined. In the present study, the RNA expression profiles for CCA were downloaded from The Cancer Genome Atlas and further analyzed. A total of 318 differentially expressed (DE) lncRNAs, 87 DE miRNAs and 3,851 DE mRNAs were identified from 36 CCA samples and 9 adjacent non-tumor samples (for lncRNAs and miRNAs, fold change ≥2.5 and P<0.01; for mRNAs, fold change ≥2 and P<0.01). Further bioinformatics analyses were performed and the ceRNA network for CCA was constructed, which included 16 lncRNAs, 55 miRNAs and 373 mRNAs. Survival analysis of all genes in the network revealed that high expression of the mRNAs fucosyltransferase 4 (P<0.005) and huntingtin-interacting protein 1 related (P<0.001) has a positive impact on the overall survival of patients with CAA. Furthermore, the lncRNAs H19 and PVT1, and the miRNAs Homo sapiens (hsa)-miR-16-5p and hsa-miR-424-5p, together with peroxisome proliferator-activated receptors, may also have important roles in the pathogenesis of CCA. The present study provided data to further the understanding of and research into the molecular mechanisms implicated in CCA.
Copyright © 2019, Spandidos Publications.

Entities:  

Keywords:  H19; PVT1; cholangiocarcinoma; competing endogenous RNAs; long-noncoding RNA; peroxisome proliferator-activated receptor

Year:  2019        PMID: 31641385      PMCID: PMC6796451          DOI: 10.3892/etm.2019.8052

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  51 in total

1.  Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells.

Authors:  Feng Yang; Jianwei Bi; Xuchao Xue; Luming Zheng; Kangkang Zhi; Jide Hua; Guoen Fang
Journal:  FEBS J       Date:  2012-07-31       Impact factor: 5.542

2.  Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.

Authors:  Li Wan; Ming Sun; Guo-Jian Liu; Chen-Chen Wei; Er-Bao Zhang; Rong Kong; Tong-Peng Xu; Ming-De Huang; Zhao-Xia Wang
Journal:  Mol Cancer Ther       Date:  2016-02-23       Impact factor: 6.261

3.  Integrating genomics and proteomics-oriented biomarkers to comprehend lung cancer.

Authors:  Nagathihalli S Nagaraj; Om V Singh
Journal:  Expert Opin Med Diagn       Date:  2009-03

4.  PPARγ Modulation of Cytokine-Stimulated MUC16 (CA125) Expression in Breast and Ovarian Cancer-Derived Cells.

Authors:  Micaela Morgado; Daniel D Carson
Journal:  J Cell Biochem       Date:  2016-06-24       Impact factor: 4.429

5.  miRDB: an online resource for microRNA target prediction and functional annotations.

Authors:  Nathan Wong; Xiaowei Wang
Journal:  Nucleic Acids Res       Date:  2014-11-05       Impact factor: 16.971

6.  The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer.

Authors:  Wei-Cheng Liang; Wei-Ming Fu; Cheuk-Wa Wong; Yan Wang; Wei-Mao Wang; Guo-Xin Hu; Li Zhang; Li-Jia Xiao; David Chi-Cheong Wan; Jin-Fang Zhang; Mary Miu-Yee Waye
Journal:  Oncotarget       Date:  2015-09-08

7.  H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation.

Authors:  Changkun Liu; Zhouguang Chen; Jianzheng Fang; Aiming Xu; Wei Zhang; Zengjun Wang
Journal:  Tumour Biol       Date:  2015-07-22

8.  Genome-wide analysis of long noncoding RNA and mRNA co-expression profile in intrahepatic cholangiocarcinoma tissue by RNA sequencing.

Authors:  Wenhui Yang; Yuan Li; Xia Song; Jun Xu; Jun Xie
Journal:  Oncotarget       Date:  2017-04-18

9.  Construction and investigation of breast-cancer-specific ceRNA network based on the mRNA and miRNA expression data.

Authors:  Xionghui Zhou; Juan Liu; Wei Wang
Journal:  IET Syst Biol       Date:  2014-06       Impact factor: 1.615

10.  Comprehensive analysis of aberrantly expressed lncRNAs and construction of ceRNA network in gastric cancer.

Authors:  Kanagaraj Arun; Ganesan Arunkumar; Duraisamy Bennet; Servarayan Murugesan Chandramohan; Avaniyapuram Kannan Murugan; Arasambattu Kannan Munirajan
Journal:  Oncotarget       Date:  2018-04-06
View more
  7 in total

1.  Long noncoding RNA OSER1‑AS1 promotes the malignant properties of non‑small cell lung cancer by sponging microRNA‑433‑3p and thereby increasing Smad2 expression.

Authors:  Xinmei Liu; Shasha Huang; Yun Guan; Qing Zhang
Journal:  Oncol Rep       Date:  2020-06-12       Impact factor: 3.906

Review 2.  Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives.

Authors:  Mirella Pastore; Giulia Lori; Alessandra Gentilini; Maria Letizia Taddei; Giovanni Di Maira; Claudia Campani; Stefania Recalcati; Pietro Invernizzi; Fabio Marra; Chiara Raggi
Journal:  Cells       Date:  2020-03-03       Impact factor: 6.600

3.  Integrated analysis of lncRNA-miRNA-mRNA ceRNA network and the potential prognosis indicators in sarcomas.

Authors:  Lu Gao; Yu Zhao; Xuelei Ma; Ling Zhang
Journal:  BMC Med Genomics       Date:  2021-03-02       Impact factor: 3.063

4.  A two-microRNA signature predicts the progression of male thyroid cancer.

Authors:  Bingyang Liu; Haihong Shi; Weigang Qiu; Xinquan Wu; Liqiong Li; Wenyi Wu
Journal:  Open Life Sci       Date:  2021-09-13       Impact factor: 1.311

5.  An immune-related microRNA signature prognostic model for pancreatic carcinoma and association with immune microenvironment.

Authors:  Qian Shen; JunChen Li; Xue Pan; ChuanLong Zhang; XiaoChen Jiang; Yi Li; Yan Chen; Bo Pang
Journal:  Sci Rep       Date:  2022-09-02       Impact factor: 4.996

6.  Identification of Prognostic Biomarkers and Correlation With Immune Infiltrates in Hepatocellular Carcinoma Based on a Competing Endogenous RNA Network.

Authors:  Zhangya Pu; Yuanyuan Zhu; Xiaofang Wang; Yun Zhong; Fang Peng; Yiya Zhang
Journal:  Front Genet       Date:  2021-05-20       Impact factor: 4.599

Review 7.  Exosomal noncoding RNAs in cholangiocarcinoma: Laboratory noise or hope?

Authors:  Konstantinos Laschos; Dimitra Ioanna Lampropoulou; Gerasimos Aravantinos; Maria Piperis; Dimitrios Filippou; George Theodoropoulos; Maria Gazouli
Journal:  World J Gastrointest Surg       Date:  2020-10-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.